The initial public offering market in 2025 marked a definitive shift, continuing its rebound from the sluggish years of 2022 and 2023. This wasn't merely a statistical uptick; it represented a tangible increase in market activity, with more IPOs, a resurgence in Special Purpose Acquisition Companies (SPACs), and a notable rise in capital raised. The year concluded with a strong finish, signaling a renewed, albeit cautious, appetite for public listings.
A total of 354 U.S. equity market IPOs were recorded, a substantial increase of 136 over 2024 and 206 over 2023. While still below the peak levels of 2021, this trajectory indicates a market finding its footing. The capital raised by non-SPAC IPOs reached $44 billion, surpassing the combined totals of 2015-2018 and significantly exceeding the $20 billion raised in 2024. This capital inflow, with 81% of new listings choosing Nasdaq, suggests a strategic re-engagement from companies seeking public funding.
Sector Dynamics and Performance Divergence
The composition of these new listings tells a story of prevailing market themes. Information Technology (IT) companies, riding the AI boom, constituted over 25% of non-SPAC IPOs. Together, IT and Industrials accounted for more than half of the year's offerings. This concentration underscores the market's focus on sectors perceived to offer high growth potential, even if the actual returns proved more complex.
Day-one returns, often referred to as the 'IPO pop,' showed a median of 13% and an average of 22%, with 71% of companies achieving a positive pop. This slight improvement over 2024 brought first-day performance closer to long-term averages. However, the subsequent performance of these IPOs revealed a more intricate picture. The initial 'pop' for 2025 listings faded more rapidly over time compared to previous years. Yet, the longer-term median returns for 2025 IPOs, particularly at the six-month mark, held up better than those from 2023 and 2024 vintages. This suggests a market that, while initially enthusiastic, quickly recalibrated its valuations, rewarding resilience over fleeting hype.
“This wasn't about pure exuberance. It was about finding value in a changed landscape.”
The performance through year-end 2025 further highlighted this selectivity. The cap-weighted return was 6.5%, while the overall median return was a modest 1.29%. The 'unicorn' phenomenon, where larger companies in 2024 were more likely to see positive returns, largely dissipated in 2025. This implies a market less swayed by sheer size or pre-IPO valuation, demanding instead a clearer path to profitability or sustainable growth from even the most prominent new entrants.
Sector-wise, Health Care stocks emerged as the strongest performers, with an average return of 39% through December 31, 2025. Consumer Staples also fared well, though represented by only a single IPO. Conversely, the Energy sector experienced the worst performance, with an average drop of 38.5%. Information Technology, despite having the most IPOs and the largest cumulative capital raise ($11.2 billion), saw its IPOs average a return of -33% by year-end. This stark divergence between initial market enthusiasm and sustained performance in the tech sector should serve as a critical data point for future investment strategies. It suggests that while the market is keen to fund innovation, particularly in AI, it is equally swift to punish those that fail to meet post-listing expectations. The demand for capital varied significantly; Health Care raised $10.6 billion across 34 companies, while Industrials, with 53 IPOs, only raised $5 billion, indicating a lower per-company capital requirement or less aggressive valuation expectations in that sector.
The Resurgence of SPACs
The SPAC market also staged a significant recovery in 2025, reaching its third-highest level on record, just behind the frenzied years of 2020 and 2021. With 88 more SPACs listed than in 2024, the instrument demonstrated renewed, if still cautious, investor interest. A notable 120 of the 2025 SPACs were still actively seeking targets by year-end, with 24 having already announced deals. This contrasts sharply with the liquidation rates seen in earlier vintages, particularly the 50% liquidation rate for 2021 SPACs, underscoring the inherent risks and the two-year window typically available for deal completion.
The median SPAC in 2025 raised $200 million, a figure largely consistent with pre-2021 levels. This indicates a return to more conservative capital-raising targets compared to the peak years. Active SPACs, still searching for targets, traded in a tight range around $10, with an average price of $10.47 and a median of $10.28. Even those that had announced deals mostly remained close to this benchmark, suggesting a market that has learned from past speculative excesses. The era of easy money for SPACs is over; the focus is now on viable targets and realistic valuations.
The market remains discerning.Looking ahead, 2025's performance sets a robust stage for 2026. The 'IPO pulse' predicts continued strength, with a pipeline of potential listings including several 'centicorns'—companies valued at $100 billion or more. Names like SpaceX, OpenAI, ByteDance, Anthropic AI, Databricks, and Stripe are frequently cited. Driven largely by ongoing investments in artificial intelligence, some estimates suggest companies worth a combined $3 trillion could go public in 2026. This potential influx of high-value listings could indeed make 2026 a historic year for the IPO market, but the lessons from 2025's nuanced performance—particularly the divergence between initial pop and sustained returns, and the selective nature of sector performance—will be crucial for navigating what promises to be a dynamic landscape. The market has shown it can absorb significant capital, but it has also demonstrated a clear preference for substance over mere speculation, a trend that is likely to intensify.
